Rifampin: mechanisms of action and resistance
- PMID: 6356275
- DOI: 10.1093/clinids/5.supplement_3.s407
Rifampin: mechanisms of action and resistance
Abstract
Rifampin specifically inhibits bacterial RNA polymerase, the enzyme responsible for DNA transcription, by forming a stable drug-enzyme complex with a binding constant of 10(-9) M at 37 C. The corresponding mammalian enzymes are not affected by rifampin. Bacterial resistance to rifampin is caused by mutations leading to a change in the structure of the beta subunit of RNA polymerase. Such resistance is not an all-or-nothing phenomenon; rather, a large number of RNA polymerases with various degrees of sensitivity to rifampin have been found. No strict correlation exists between enzyme sensitivity and MIC values, since inhibition of RNA synthesis does not always show up to the same extent in the two different test systems used for the determination of these values.
Similar articles
-
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus.Antimicrob Agents Chemother. 2000 Nov;44(11):3163-6. doi: 10.1128/AAC.44.11.3163-3166.2000. Antimicrob Agents Chemother. 2000. PMID: 11036042 Free PMC article.
-
Different rifampin sensitivities of Escherichia coli and Mycobacterium tuberculosis RNA polymerases are not explained by the difference in the beta-subunit rifampin regions I and II.Antimicrob Agents Chemother. 2005 Apr;49(4):1587-90. doi: 10.1128/AAC.49.4.1587-1590.2005. Antimicrob Agents Chemother. 2005. PMID: 15793146 Free PMC article.
-
[Nucleotide substitutions in the rpoB gene leading to rifampicin resistance of E. coli RNA polymerase].Bioorg Khim. 1984 Jan;10(1):127-8. Bioorg Khim. 1984. PMID: 6385989 Russian.
-
Resistance to rifampicin: a review.J Antibiot (Tokyo). 2014 Sep;67(9):625-30. doi: 10.1038/ja.2014.107. Epub 2014 Aug 13. J Antibiot (Tokyo). 2014. PMID: 25118103 Review.
-
Mutational analysis of structure-function relationship of RNA polymerase in Escherichia coli.Methods Enzymol. 1996;273:300-19. doi: 10.1016/s0076-6879(96)73027-6. Methods Enzymol. 1996. PMID: 8791620 Review. No abstract available.
Cited by
-
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.Antimicrob Agents Chemother. 1990 Jun;34(6):1014-6. doi: 10.1128/AAC.34.6.1014. Antimicrob Agents Chemother. 1990. PMID: 2393259 Free PMC article.
-
Molecular basis of rifampin resistance in Streptococcus pneumoniae.Antimicrob Agents Chemother. 1999 Oct;43(10):2361-5. doi: 10.1128/AAC.43.10.2361. Antimicrob Agents Chemother. 1999. PMID: 10508007 Free PMC article.
-
Tackling antimicrobial stewardship through synergy and antimicrobial peptides.RSC Med Chem. 2022 Apr 4;13(5):511-521. doi: 10.1039/d2md00048b. eCollection 2022 May 25. RSC Med Chem. 2022. PMID: 35694695 Free PMC article. Review.
-
Antibiotic-Derived Radiotracers for Positron Emission Tomography: Nuclear or "Unclear" Infection Imaging?Angew Chem Int Ed Engl. 2022 Nov 7;61(45):e202204955. doi: 10.1002/anie.202204955. Epub 2022 Sep 20. Angew Chem Int Ed Engl. 2022. PMID: 35834311 Free PMC article. Review.
-
Rapid loss of a green fluorescent plasmid in Escherichia coli O157:H7.AIMS Microbiol. 2017 Oct 25;3(4):872-884. doi: 10.3934/microbiol.2017.4.872. eCollection 2017. AIMS Microbiol. 2017. PMID: 31294194 Free PMC article.